Sequencely, the relatievely lower level of VEGFR2 can be tested in normal rats, compared to untreated COPD rats (Fig. 4C, P = 0.030 < 0.05), and it suggested no difference between rats dealt with NS or sunitinib. Here, KDR is linked to chronic obstructive pulmonary disease.